Evidence map›Paper›PMID 38838816›Full record

ReviewMucosal immunology2024

Local complement activation and modulation in mucosal immunity.

Devesha H Kulkarni, Marick Starick, Rafael Aponte Alburquerque, Hrishikesh S Kulkarni

Abstract readReview
In one paragraph

Review in Mucosal immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Divergent roles for complement components C3 and C4 in controllingbioRxiv : the preprint server for biology · 2025
    Article
  12. Emerging roles for complement in lung transplantation.The Journal of clinical investigation · 2025
    Review
  13. Vaginal Clinical Isolates ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Devesha H KulkarniDivision of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.
Marick StarickDivision of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Rafael Aponte AlburquerqueDivision of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Hrishikesh S KulkarniDivision of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: hkulkarn@wustl.edu.

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
Lung epithelial cell-derived C3 in acute lung injuryR01HL169860 · NHLBI · WASHINGTON UNIVERSITY · PI Hrishikesh Satish Kulkarni · 2023 to 2026
$2.3M
Lung-derived complement in pneumoniaR01HL166449 · NHLBI · WASHINGTON UNIVERSITY · PI Hrishikesh Satish Kulkarni · 2023 to 2026
$2.2M
Microbial drivers of metabolically unhealthy obese phenotypeK01DK133670 · NIDDK · WASHINGTON UNIVERSITY · PI Devesha Kulkarni · 2022 to 2026
$839k
C3 Mitigates Epithelial Injury in PneumoniaK08HL148510 · NHLBI · WASHINGTON UNIVERSITY · PI KULKARNI, HRISHIKESH SATISH · 2019 to 2023
$740k
NHLBI NIH HHS K08 HL148510NHLBI NIH HHS R01 HL166449NHLBI NIH HHS R01 HL169860NIDDK NIH HHS K01 DK133670NIDDK NIH HHS P30 DK056341
6 · The paper itself

Abstract

The complement system is an evolutionarily conserved arm of innate immunity, which forms one of the first lines of host response to pathogens and assists in the clearance of debris. A deficiency in key activators/amplifiers of the cascade results in recurrent infection, whereas a deficiency in regulating the cascade predisposes to accelerated organ failure, as observed in colitis and transplant rejection. Given that there are over 60 proteins in this system, it has become an attractive target for immunotherapeutics, many of which are United States Food and Drug Administration-approved or in multiple phase 2/3 clinical trials. Moreover, there have been key advances in the last few years in the understanding of how the complement system operates locally in tissues, independent of its activities in circulation. In this review, we will put into perspective the abovementioned discoveries to optimally modulate the spatiotemporal nature of complement activation and regulation at mucosal surfaces.

Indexed as

Complement ActivationComplement System ProteinsImmunity, MucosalAnimalsHumansImmunity, InnateImmunomodulationComplement System ProteinsATG7autophagy related 7C3 fast/slowC3 F/SCCAATchemokine (C-X-C motif) ligandCXCLcytosine-cytosine-adenosine-adenosine-thymidinedextran sodium sulfateDSSfarnesoid X receptorFXRherpes simplex virus-1HSV-1ICAMintercellular adhesion moleculeinterferon regulatory factorIRFJAK1/2Janus kinase ½MAPKmatrix metalloproteinasemitogen-activated protein kinaseMMPNLRP3nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3peroxisome proliferator-activated receptorphosphatase and tensin homologPPARPTENreactive oxygen speciesRELA - v-relreticuloendotheliosis viral oncogene homolog A (avian)ROSsignal transducer and activation of transcription 1STAT1vascular endothelial growth factor-AVEGF-A

Identifiers

PMID38838816
PMCPMC11929374

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.